Lista de obras -

"No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment

scientific article published on 18 December 2013

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials ⬇️

artículo científico publicado el 1 de octubre de 2003

1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience

artículo científico publicado en 2019

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

800Infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation at a high-volume, academic, transplant center.

artículo científico publicado en 2014

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)

A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning

artículo científico publicado en 2016

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2020

A TAD better for myeloma therapy?

artículo científico publicado en 2010

A key step towards setting a benchmark for tackling transplant-associated thrombotic microangiopathy

artículo científico publicado en 2020

A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation

artículo científico publicado en 2013

A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma

artículo científico publicado en 2014

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

artículo científico publicado en 2020

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study

artículo científico publicado en 2020

A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients

artículo científico publicado en 2013

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

artículo científico publicado en 2009

A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.

artículo científico publicado en 2007

A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies

artículo científico publicado en 2014

A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients

artículo científico publicado en 2009

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

artículo científico publicado en 2011

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

artículo científico publicado en 2013

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas

artículo científico

A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT)

artículo científico publicado en 2021

Accelerated single cell seeding in relapsed multiple myeloma

artículo científico publicado en 2020

Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial

artículo científico publicado en 2017

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

artículo científico publicado en 2004

Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia

artículo científico publicado en 1993

Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact

artículo científico publicado en 2015

Adenovirus infections in adult recipients of blood and marrow transplants

artículo científico publicado en 2001

Adenovirus viral kinetics and mortality in ex-vivo T-cell depleted hematopoietic cell transplant recipients with adenovirus infection from a single center

artículo científico publicado en 2020

Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.

artículo científico publicado en 2012

Adult Henoch-schönlein purpura in a patient with myelodysplastic syndrome and a history of follicular lymphoma.

artículo científico publicado en 2008

Advances in stem cell transplantation: making it better and safer

scientific article published on January 2009

Adverse effects of molgramostim in marrow transplant recipients

artículo científico publicado en 1993

Aging, acute myelogenous leukemia, and allogeneic transplantation: do they belong in the same sentence?

scientific article published on August 2009

Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease

artículo científico publicado en 2008

Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Where Are We Going With This?

artículo científico publicado en 2016

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes

artículo científico publicado en 2017

Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia

artículo científico

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2018

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

artículo científico publicado en 1997

Allogeneic blood stem cell transplantation in advanced hematologic cancers

artículo científico publicado en 1997

Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation

artículo científico publicado el 1 de septiembre de 1992

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

artículo científico

Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP 53 alterations

artículo científico publicado en 2018

Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date.

artículo científico publicado en 2007

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

artículo científico publicado en 2006

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

artículo científico publicado en 2017

Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care

artículo científico publicado en 2012

Allogeneic hematopoietic stem cell transplantation for multiple myeloma: what place, if any?

artículo científico

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

artículo científico publicado en 2007

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

artículo científico publicado en 2013

Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study ⬇️

artículo científico publicado el 1 de mayo de 2003

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

artículo científico publicado en 1999

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

artículo científico publicado en 2000

Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens

artículo científico publicado en 2000

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

scientific article published on 01 November 1999

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases

artículo científico publicado en 1998

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

scientific article published on 01 March 1998

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

scientific article published on 01 May 2000

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

artículo científico publicado en 2014

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

scientific article published on 01 August 2020

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

artículo científico publicado en 2010

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

artículo científico publicado en 2006

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

artículo científico publicado en 2000

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

scientific article published on 01 December 1996

Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients

artículo científico publicado el 1 de agosto de 1997

Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome

artículo científico publicado en 2006

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia

artículo científico publicado en 2004

Allografting older patients--myths and realities

artículo científico publicado en 2009

Analysis of Chimerism Following Allogeneic Bone Marrow Transplantation by Fluorescent-in-Situ Hybridization ⬇️

artículo científico publicado el 1 de mayo de 1997

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration

artículo científico publicado en 2013

Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation

artículo científico publicado en 2003

Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial

artículo científico publicado en 2008

Assessing response of therapy for acute and chronic graft-versus-host disease

artículo científico

Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation

artículo científico publicado en 2011

Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation

artículo científico publicado en 2015

Authors' reply to Tendas et al.

artículo científico publicado en 2013

Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up

artículo científico publicado en 2014

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.

artículo científico publicado en 2019

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

artículo científico publicado en 1994

Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions

artículo científico publicado en 2003

Autologous bone marrow transplantation for leukemia and lymphoma.

artículo científico publicado en 1996

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

artículo científico publicado en 2011

Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

artículo científico publicado en 2009

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia

artículo científico publicado en 2006

Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma

scientific article published on 29 January 2007

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission

artículo científico publicado en 2004

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes

artículo científico publicado en 2002

BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation.

artículo científico publicado en 2013

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

artículo científico publicado en 2018

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007

artículo científico publicado en 2007

Blood and marrow transplant clinical trials network state of the Science Symposium 2014

artículo científico publicado en 2014

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

artículo científico publicado en 2005

Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.

artículo científico publicado en 2004

Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.

artículo científico publicado en 2005

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

scientific article published on 01 January 1997

Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center.

artículo científico publicado en 2018

Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults

CAR T cell therapy for multiple myeloma: where are we now and where are we headed?

artículo científico publicado en 2017

CAR-T - and a side order of IgG, to go? - Immunoglobulin replacement in patients receiving CAR-T cell therapy

scientific article published on 07 August 2019

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

artículo científico publicado en 2018

CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma

scientific article published on 01 July 2019

CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .

artículo científico publicado en 2018

CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma

scientific article published on 29 August 2015

CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse

artículo científico publicado en 2015

CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study

artículo científico publicado en 2004

CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

artículo científico publicado en 1995

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

artículo científico publicado en 1999

Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty

artículo científico publicado en 2012

Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients

artículo científico publicado en 2020

Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies.

artículo científico publicado en 2000

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

artículo científico publicado en 2001

Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.

artículo científico publicado en 2002

Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma

artículo científico publicado en 2002

Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma

artículo científico publicado en 2004

Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34+ Selected Hematopoietic Cell Transplantation.

artículo científico publicado en 2017

Collection of peripheral blood stem cells from normal donors 60 years of age or older

artículo científico publicado en 1997

Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management

artículo científico publicado en 2020

Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma

artículo científico publicado en 2004

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

artículo científico publicado en 2002

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

artículo científico publicado en 2015

Comparison of twin and autologous transplants for multiple myeloma

artículo científico publicado en 2008

Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity

artículo científico publicado en 2001

Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma

artículo científico publicado en 2008

Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue

artículo científico publicado en 1997

Compliments to complement blockade for TA-TMA

artículo científico publicado en 2020

Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria

artículo científico publicado en 2020

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

artículo científico publicado en 2010

Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

artículo científico publicado en 2015

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

artículo científico publicado en 2011

Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation

artículo científico publicado en 2016

Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes

scientific article published on 24 November 2018

Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients

artículo científico publicado en 2001

Cytomegalovirus resistance in CD34+ -selected hematopoietic cell transplant recipients.

artículo científico publicado en 2018

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

artículo científico publicado en 2000

Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study

artículo científico publicado en 2001

Defining the intensity of conditioning regimens: working definitions

artículo científico publicado en 2009

Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.

artículo científico publicado en 1996

Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant

scientific article published on 16 July 2007

Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry

artículo científico publicado en 2021

Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities

artículo científico publicado en 2005

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

scientific article published on 01 July 2005

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.

artículo científico publicado en 2008

Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioned Autologous Stem Cell Transplantation.

artículo científico publicado en 2018

Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice

artículo científico publicado en 2014

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

artículo científico publicado en 1997

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center

artículo científico publicado en 2012

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response

artículo científico publicado en 2004

Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis

artículo científico publicado en 2001

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

artículo científico publicado en 2009

Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study

artículo científico publicado en 2012

Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units

artículo científico publicado en 2002

Drug safety evaluation of defibrotide

artículo científico

Durable remission with salvage second autotransplants in patients with multiple myeloma

artículo científico publicado en 2011

Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant

artículo científico publicado en 2012

Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2018

Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia

scientific article published on 01 May 2000

Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy

scientific article published on 05 March 2020

Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant

artículo científico publicado en 2017

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

artículo científico publicado en 2010

Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia

scientific article published on 01 June 1993

Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.

artículo científico publicado en 1993

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

artículo científico publicado en 2014

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

artículo científico publicado en 2008

End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center

scientific article published on 22 August 2018

Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin

scientific article published on 18 June 2020

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

scientific article published on 01 June 1997

Epidermodysplasia verruciformis in the setting of graft-versus-host disease

Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Di

artículo científico publicado en 2016

Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease

scientific article published on 13 October 2019

Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission

artículo científico publicado en 2013

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

scholarly article by Florent Malard published in October 2018

Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma

artículo científico publicado en 2011

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

artículo científico publicado en 2005

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

artículo científico publicado en 2003

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graft

scientific article published on 23 October 2019

Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma

artículo científico publicado en 2014

Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

artículo científico publicado en 2020

Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - a single institution pilot study

scientific article published on 21 June 2019

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

artículo científico publicado en 2009

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma

artículo científico publicado en 2011

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

artículo científico publicado en 2021

Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma

scientific article published on 01 June 2006

Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia ⬇️

artículo científico publicado el 12 de octubre de 2010

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

artículo científico publicado en 2008

Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes

artículo científico publicado en 2009

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma

artículo científico publicado en 2002

Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir

artículo científico publicado en 1997

Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.

artículo científico publicado en 2016

Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin

artículo científico publicado en 2014

Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation

artículo científico publicado en 2017

Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes

artículo científico publicado en 2020

Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation

artículo científico publicado en 2020

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

artículo científico publicado en 2020

Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization

artículo científico publicado en 2020

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia

artículo científico publicado en 2007

Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia

scientific article published on 01 September 1996

Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality

artículo científico publicado en 1999

Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials

artículo científico publicado en 2015

Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2016

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

artículo científico publicado en 2022

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

artículo científico publicado en 2000

Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study

artículo científico publicado en 2016

Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.

artículo científico publicado en 2016

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2020

Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.

artículo científico publicado en 2015

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

artículo científico publicado en 2007

Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy

artículo científico publicado en 2010

Hematopoietic progenitor cell transplantation in 2007: new challenges and new opportunities for the center for international blood and marrow transplant research

artículo científico publicado en 2007

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

scientific article published on 01 August 2020

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters

artículo científico publicado en 2004

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

artículo científico publicado en 2010

Hepatic haematoma after allogeneic transplantation.

artículo científico publicado en 2003

Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome

artículo científico publicado en 2009

Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations

artículo científico

High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia

artículo científico publicado en 2015

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

artículo científico publicado en 2014

High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia

artículo científico publicado en 1994

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults

scientific article published on 01 December 2020

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation

artículo científico publicado en 2009

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

artículo científico publicado en 2008

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.

artículo científico publicado en 2006

High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia

artículo científico publicado en 2001

High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome

artículo científico publicado en 1998

High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity

artículo científico publicado el 1 de abril de 1995

High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer

artículo científico publicado en 2000

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant

scientific article published on 01 August 2000

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma

artículo científico publicado en 2006

High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma

artículo científico publicado en 2004

Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis

artículo científico publicado en 2015

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

artículo científico publicado en 1998

Hyperacute GVHD: risk factors, outcomes, and clinical implications

artículo científico publicado en 2007

Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee

artículo científico publicado en 2014

Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer

artículo científico publicado en 2003

Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.

artículo científico publicado en 2002

Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation

scientific article published on 06 January 2019

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance

artículo científico publicado en 2017

Impact and safety of chimeric antigen receptor T cell therapy in older, vulnerable patients with relapsed/refractory large b-cell lymphoma

scientific article published on 20 February 2020

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

artículo científico publicado en 2019

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

scientific article published on 06 January 2019

Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice. A Retrospective Single Center Cohort Study

artículo científico publicado en 2020

Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2017

Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma

scientific article published on 13 May 2020

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

article by R Alexanian et al published May 2001 in Bone Marrow Transplantation

Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

scientific article published on 30 August 2019

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

artículo científico publicado en 2009

Impact of high-dose chemotherapy on peripheral T-cell lymphomas

artículo científico publicado en 2001

Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.

artículo científico publicado en 2007

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study

artículo científico publicado en 2014

Impact of preemptive therapy for Cytomegalovirus on hospitalizations and cost after Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2020

Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies

scientific article published on 01 November 1996

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

artículo científico publicado en 2008

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma

artículo científico publicado en 2009

Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.

artículo científico publicado en 2016

Importance of achieving a complete response in multiple myeloma, and the impact of novel agents

scientific article published on 12 April 2010

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood Transplantation

artículo científico publicado en 2020

Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant

artículo científico publicado en 2014

Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2007

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

artículo científico publicado en 2017

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

artículo científico publicado en 2015

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy

artículo científico publicado en 2020

Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts

artículo científico publicado en 2010

Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation

artículo científico publicado en 2015

Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma

artículo científico publicado en 1999

Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation

artículo científico publicado el 1 de junio de 1995

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

artículo científico publicado en 2009

International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma

artículo científico publicado en 2010

International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

artículo científico publicado en 2020

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

scientific article published on 01 June 2019

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

artículo científico publicado en 2015

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

artículo científico publicado en 2017

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2010

Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

scientific article published on 14 January 2020

Lactose drives Enterococcus expansion to promote graft-versus-host disease

scientific article published on 01 November 2019

Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients

artículo científico publicado en 1999

Lenalidomide after stem-cell transplantation for multiple myeloma

artículo científico publicado en 2012

Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2014

Letermovir for prevention of cytomegalovirus reactivation in haploidentical and mismatched adult donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide for graft-versus-host disease prophylaxis

artículo científico publicado en 2020

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience

scientific article published on 21 October 2019

Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.

artículo científico publicado en 2008

Leukemia relapse after allogeneic bone marrow transplantation: a review

scientific article published on 01 December 1994

Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants

artículo científico publicado en 2017

Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

artículo científico publicado en 2001

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias

artículo científico publicado en 2003

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes

artículo científico publicado en 2011

Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia

artículo científico publicado en 2007

Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis

artículo científico publicado en 2008

Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients

scientific article published on 01 January 1999

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

artículo científico publicado en 2011

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

artículo científico publicado en 2017

Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant

artículo científico publicado en 2012

Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation

scientific article published on 14 April 2020

Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia

scientific article published on 06 December 2018

Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS.

artículo científico publicado en 2016

Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.

artículo científico publicado en 2005

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

artículo científico publicado en 2009

Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.

artículo científico publicado en 1993

MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

artículo científico publicado en 2022

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study

artículo científico publicado en 2010

Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.

artículo científico publicado en 2018

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

artículo científico publicado en 1997

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

artículo científico publicado en 2009

Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry

scientific article published on 04 July 2019

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

artículo científico publicado en 2001

Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation

artículo científico publicado en 2009

Microbe-derived short chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

scientific article published on 19 May 2020

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

artículo científico publicado en 2020

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

artículo científico publicado en 2009

Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation

artículo científico publicado en 2017

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MA

scientific article published on 30 September 2020

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

artículo científico publicado en 2017

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

artículo científico publicado en 2011

Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges

artículo científico publicado en 2012

Myeloid-derived suppressor cells: The green light for myeloma immune escape.

artículo científico publicado en 2016

Myeloma in Elderly Patients: When Less Is More and More Is More

artículo científico publicado en 2017

NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic ma

artículo científico publicado en 2010

NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic

scientific article published on 10 February 2010

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

artículo científico publicado en 2010

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All

artículo científico publicado en 2010

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr

artículo científico publicado en 2010

NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic

artículo científico publicado en 2010

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following all

artículo científico publicado en 2010

NCMP-07. CLINICAL NEUROLOGICAL FEATURES AND ELECTROGRAPHIC PATTERNS OF PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH AXICABTAGENE CILOLEUCEL AT MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC)

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee

artículo científico publicado en 2011

Non myeloablative "mini transplants".

artículo científico publicado en 1999

Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era

artículo científico publicado en 2015

Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.

artículo científico publicado en 2002

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

artículo científico publicado en 2001

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

artículo científico publicado en 2004

Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes

artículo científico publicado en 2002

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

scientific article published on 15 April 2004

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

artículo científico publicado en 2004

Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

artículo científico publicado en 2009

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation

artículo científico publicado en 2001

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.

artículo científico publicado en 2003

Nonmyeloablative reduced-intensity transplantation in multiple myeloma

artículo científico publicado en 2004

Nonmyeloablative stem cell transplantation for chronic myeloid leukemia

artículo científico publicado en 2004

Normal hematopoietic function and multiple bone marrow clonal abnormalities in a patient with acute myeloid leukemia after two mismatched stem-cell transplants with graft failure and autologous reconstitution

scientific article published on 01 August 2007

Novel agents may positively impact chemotherapy and transplantation in subsets of diffuse large B-cell lymphoma

artículo científico publicado en 2019

Novel agents positively impact chemotherapy and transplantation in Hodgkin lymphoma

scientific article published on 21 March 2019

Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity

scientific article published on 01 July 2007

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

artículo científico publicado en 2020

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

artículo científico publicado en 2008

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

artículo científico publicado en 2004

Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates

artículo científico publicado en 2014

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations

artículo científico

Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction

artículo científico publicado en 2009

Outcome of bone marrow transplantation patients requiring mechanical ventilation

artículo científico publicado en 2000

Outcome of transplantation for myelofibrosis

artículo científico publicado en 2009

Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2013

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy

artículo científico publicado en 2004

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.

artículo científico publicado en 2016

Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of a

artículo científico publicado en 1995

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation

artículo científico

Phase 1/2 Trial of Carfilzomib Plus High Dose Melphalan Preparative Regimen for Salvage AHCT Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma

artículo científico publicado en 2018

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

artículo científico publicado en 2016

Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

artículo científico publicado en 2019

Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue

scientific article published on 01 February 1997

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

artículo científico publicado en 2007

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma

artículo científico publicado en 2016

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O

article

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

artículo científico publicado en 2001

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma

artículo científico publicado en 2004

Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies

artículo científico publicado en 2006

Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma

artículo científico publicado en 2010

Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis

scientific article published on 22 August 2019

Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation

artículo científico publicado en 2020

Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.

artículo científico publicado en 2011

Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma

artículo científico publicado en 2009

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity.

artículo científico publicado en 2018

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

artículo científico publicado en 2012

Presalvage International Staging System Stage and Other Important Outcome Associations in CD34+-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

scientific article published on 05 September 2019

Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience.

artículo científico publicado en 2018

Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia

artículo científico publicado en 2020

Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation

artículo científico publicado en 2006

Principles and overview of allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2009

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transpl

scientific article published on 07 September 2013

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation.

artículo científico publicado en 2013

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction

artículo científico publicado en 2013

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory

artículo científico publicado en 2013

Prognostic Factors for Post-Relapse Survival after ex-vivo CD34+-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

artículo científico publicado en 2020

Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2015

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

scientific article published on 28 June 2019

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

artículo científico publicado en 2004

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

scientific article published on 10 October 2011

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

artículo científico publicado en 2005

Prognostic value of response after upfront therapy for acute GVHD ⬇️

artículo científico publicado el 7 de marzo de 2011

Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study

artículo científico publicado en 2010

Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection

artículo científico publicado en 2017

Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

artículo científico publicado en 2006

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

artículo científico publicado en 2002

Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2017

Proteomic profiling in plasma cell disorders: a feasibility study

artículo científico publicado en 2016

Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia

artículo científico publicado en 2009

Quantitative Sensory Findings in Patients With Bortezomib-Induced Pain

artículo científico publicado en 2006

Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant

artículo científico publicado en 2011

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

scientific article published on 01 February 2000

Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical tri

artículo científico publicado en 2014

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

artículo científico publicado en 2003

Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation

artículo científico publicado en 2004

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

artículo científico publicado en 2009

Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis

artículo científico publicado en 2006

Recommend upfront consolidation with high-dose melphalan and autologous stem cell support

artículo científico publicado en 2016

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant

scientific article published on 01 September 2018

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.

artículo científico publicado en 2012

Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation

artículo científico publicado en 2011

Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma

artículo científico publicado en 2010

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

scientific article published on 01 May 2005

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

artículo científico publicado en 2003

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

artículo científico publicado en 2007

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

artículo científico publicado en 2009

Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years?

artículo científico publicado en 2005

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.

artículo científico publicado en 2009

Reducing the toxicity of cancer therapy: recognizing needs, taking action

artículo científico publicado en 2012

Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial

scientific article published on 01 March 2020

Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect

artículo científico publicado en 1999

Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy

artículo científico publicado en 1999

Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy

artículo científico publicado en 2021

Relapse after allogeneic hematopoietic cell therapy.

artículo científico publicado en 2009

Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations

artículo científico publicado en 2014

Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group

artículo científico publicado en 2010

Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 06 January 2010

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

artículo científico publicado en 2000

Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes

artículo científico publicado en 2007

Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

artículo científico publicado en 2010

Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience

scientific article published on 01 May 1996

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.

artículo científico publicado en 2017

Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and M

artículo científico publicado el 10 de enero de 2011

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

artículo científico publicado en 2007

Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

artículo científico publicado en 1999

Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma

artículo científico publicado en 2006

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma

artículo científico publicado en 2002

Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia.

artículo científico publicado en 2005

Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin

artículo científico publicado en 2020

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies

artículo científico publicado en 2015

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

artículo científico publicado en 2000

Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.

artículo científico publicado en 2015

Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease

artículo científico publicado en 2012

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

artículo científico publicado en 2020

Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma

artículo científico publicado en 2019

Salvage second hematopoietic cell transplantation in myeloma

artículo científico publicado en 2013

Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation

artículo científico publicado en 2005

Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa

artículo científico publicado en 2016

Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma

artículo científico publicado en 2006

Second autologous stem cell transplant: an effective therapy for relapsed multiple myeloma

artículo científico publicado en 2014

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

artículo científico publicado en 2004

Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia

artículo científico publicado el 1 de enero de 1992

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin

artículo científico publicado en 2011

Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2008

Severe pembrolizumab-associated neutropenia after CD34+ selected allogeneic hematopoietic-cell transplantation for multiple myeloma.

artículo científico publicado en 2018

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

artículo científico publicado en 2002

Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma

artículo científico publicado en 2014

Significant Nationwide Variability in the Costs and Hospital Mortality Rates of Autologous Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample Database

scientific article published on 06 September 2018

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

artículo científico publicado en 2011

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

artículo científico publicado en 2005

Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant.

artículo científico publicado en 2014

Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

scientific article published on 01 March 2019

Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity 1 with Novel Induction Regimens in Multiple Myeloma

artículo científico publicado en 2020

Stem cell transplantation for multiple myeloma: current and future status

artículo científico publicado en 2012

Stem cell transplantation for multiple myeloma: current and future status

artículo científico publicado en 2011

Stem cell transplantation for multiple myeloma: current status and future directions.

artículo científico publicado en 2004

Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I.

artículo científico publicado en 2010

Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy

artículo científico publicado en 2006

Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma

artículo científico publicado en 2018

Studies of decitabine with allogeneic progenitor cell transplantation

artículo científico publicado en 1997

Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy ⬇️

artículo científico publicado el 1 de octubre de 1997

Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies

artículo científico publicado en 2014

Symptom burden after autologous stem cell transplantation for multiple myeloma

artículo científico publicado en 2008

Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation

artículo científico publicado en 2012

Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma

artículo científico publicado en 2018

T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies

artículo científico publicado en 2017

T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease

artículo científico publicado en 2012

T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation

artículo científico publicado en 1996

T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy

artículo científico publicado en 2015

T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma

artículo científico publicado en 1992

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

artículo científico publicado en 1999

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.

artículo científico publicado en 1996

Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.

artículo científico publicado en 2000

Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.

artículo científico publicado en 2003

Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial

artículo científico publicado en 2019

The Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.

artículo científico publicado en 2017

The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes

artículo científico publicado en 2009

The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.

artículo científico publicado en 2017

The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies

artículo científico publicado en 2021

The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation

artículo científico publicado en 2020

The current landscape of multiple myeloma treatment

artículo científico publicado en 2008

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2014

The emerging role of consolidation and maintenance therapy for transplant-eligible multiple myeloma patients

artículo científico publicado en 2014

The future of autologous stem cell transplantation in myeloma

artículo científico publicado en 2014

The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients

artículo científico publicado en 2020

The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation

artículo científico publicado el 1 de junio de 1997

The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes

artículo científico publicado en 2010

The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months

artículo científico publicado en 2016

The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies

artículo científico publicado en 2014

The role of alemtuzumab in nonmyeloablative hematopoietic transplantation

artículo científico publicado en 2006

The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG)

scholarly article by Charalampia Kyriakou et al published 26 February 2019 in Blood Cancer Journal

The use of back-up units to enhance the safety of unrelated donor cord blood transplantation

artículo científico publicado en 2012

Therapy for older AML patients: the role of novel agents and allogeneic stem cell transplant

artículo científico publicado en 2008

Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia

artículo científico publicado en 1999

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

artículo científico publicado en 2001

Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma

artículo científico publicado en 2001

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease

scientific article published on 01 March 2019

Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment

artículo científico publicado en 2007

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

artículo científico publicado en 1998

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

scientific article published on 05 July 2007

Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib

artículo científico publicado en 2011

Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation

artículo científico publicado en 2007

Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2.

artículo científico publicado en 1995

Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood

artículo científico publicado en 2016

Treatment of relapse after allogeneic bone marrow transplantation.

artículo científico publicado en 1996

Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab

artículo científico publicado en 2003

Treatment of transplant-eligible patients with multiple myeloma in 2014.

artículo científico

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

artículo científico publicado en 2003

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

artículo científico publicado en 2004

Unlocking the Complex Flavors of Dysgeusia after Hematopoietic Cell Transplantation.

artículo científico publicado en 2017

Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission ⬇️

artículo científico publicado el 16 de noviembre de 2010

Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research

artículo científico publicado en 2005

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

artículo científico publicado en 2009

Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant ⬇️

artículo científico publicado el 1 de diciembre de 2003

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

artículo científico publicado en 2017

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency

artículo científico publicado en 2016

Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series

scientific article published on 18 May 2020

Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases

scientific article published on 01 January 1999

Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies ⬇️

artículo científico publicado el 1 de noviembre de 1997

Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma

artículo científico publicado en 2003

Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization

artículo científico publicado en 2002

Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia

artículo científico publicado en 1997

Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma

artículo científico publicado en 2017

Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.

artículo científico publicado en 2004

Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation

artículo científico publicado en 2017

Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities.

artículo científico publicado en 2018

Vitiligo Following Autologous Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2020

What Did We Learn in 2010 from the Phase III Trials? Is Maintenance Therapy the New Standard for Myeloma? ⬇️

artículo científico publicado el 1 de enero de 2011

Lista de obras de

"No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials ⬇️

1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

800Infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation at a high-volume, academic, transplant center.

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)

A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

A TAD better for myeloma therapy?

A key step towards setting a benchmark for tackling transplant-associated thrombotic microangiopathy

A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation

A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study

A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.

A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies

A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas

A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT)

Accelerated single cell seeding in relapsed multiple myeloma

Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia

Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact

Adenovirus infections in adult recipients of blood and marrow transplants

Adenovirus viral kinetics and mortality in ex-vivo T-cell depleted hematopoietic cell transplant recipients with adenovirus infection from a single center

Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.

Adult Henoch-schönlein purpura in a patient with myelodysplastic syndrome and a history of follicular lymphoma.

Advances in stem cell transplantation: making it better and safer

Adverse effects of molgramostim in marrow transplant recipients

Aging, acute myelogenous leukemia, and allogeneic transplantation: do they belong in the same sentence?

Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease

Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Where Are We Going With This?

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes

Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

Allogeneic blood stem cell transplantation in advanced hematologic cancers

Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP 53 alterations

Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date.

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care

Allogeneic hematopoietic stem cell transplantation for multiple myeloma: what place, if any?

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study ⬇️

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients

Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia

Allografting older patients--myths and realities

Analysis of Chimerism Following Allogeneic Bone Marrow Transplantation by Fluorescent-in-Situ Hybridization ⬇️

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration

Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation

Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial

Assessing response of therapy for acute and chronic graft-versus-host disease

Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation

Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation

Authors' reply to Tendas et al.